CVS CVS Health
CVS Health (CVS) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $187.3M.
Where they traded
Last open-market purchase: January 23, 2025 — 1.7 years ago, by Nelson Steven H .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| ROBBINS LARRY | Director | Sell | 370,462 | $93.45 | $34.6M | 4,824,799 −7.1% of holding | |
| ROBBINS LARRY 4 fills | Director | Sell | 1,018,000 | $93.82 | $95.5M | 5,415,633 −15.8% of holding | |
| ROBBINS LARRY 2 fills | Director | Sell | 1,983,538 | $94.45 | $187.3M | 6,213,412 −24.2% of holding | |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | Sell | 69,551 | $89.58 | $6.2M | 10,133 −87.3% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.